Pharmaceutical Market Forecasts Project Growth for Isonicotinamide and siRNA Therapeutics

H&I Global Research released a market report projecting the global pharmaceutical‑grade isonicotinamide market to reach approximately ¥41.8 billion in 2025 and to grow at an average annual rate of 4.6% over the next five years. The report surveys regional dynamics across North America, Europe, Asia‑Pacific and emerging markets, outlining key drivers, challenges and competitive landscapes.

Astute Analytica’s forecast for the global siRNA therapeutics market anticipates a valuation of $21 billion by 2025, expanding to $90 billion by 2035 with a compound annual growth rate of 15.7% from 2026 onward. The analysis highlights accelerating adoption of RNA‑interference technologies, advances in delivery platforms such as lipid nanoparticles, and expanding pipelines targeting rare diseases, oncology, cardiovascular and metabolic disorders.

Both reports underline the broader trend of precision medicine and RNA‑based drug development reshaping pharmaceutical market expectations worldwide.